title: Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma.
authors.affiliation: Yale Transplant Dermatology Clinic, New Haven, Connecticut.
authors.forename: Abigail H
authors.initials: AH
authors.lastname: Waldman
authors.affiliation: Yale Department of Dermatology, New Haven, Connecticut.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: McNiff
authors.affiliation: Yale-New Haven Transplantation Center, New Haven, Connecticut.
authors.forename: AnnMarie
authors.initials: A
authors.lastname: Liapakis
authors.affiliation: Yale-New Haven Transplantation Center, New Haven, Connecticut.
authors.forename: William S
authors.initials: WS
authors.lastname: Asch
authors.affiliation: Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, Sleepy Hollow, New York.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Smith-Marrone
authors.affiliation: Yale Transplant Dermatology Clinic, New Haven, Connecticut; Yale Department of Dermatology, New Haven, Connecticut; Yale-New Haven Transplantation Center, New Haven, Connecticut; Yale Cancer Center, New Haven, Connecticut.
authors.forename: Oscar R
authors.initials: OR
authors.lastname: Colegio
keywords: PET, positron emission tomography; PI3K, phosphatidylinositol-3 kinase; SCC, squamous cell carcinoma; SOTR, solid organ transplant recipient; calcineurin inhibitor; mTOR, mammalian target of rapamycin; mammalian target of rapamycin inhibitor; rapamycin; sirolimus; tacrolimus; undifferentiated carcinoma